{"nct_id":"NCT01891643","title":"PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Previously Untreated Multiple Myeloma (ELO 1 Substudy)","status":"TERMINATED","status_verified_date":"2021-06","start_date":"2013-09-30","start_date_type":"ACTUAL","primary_completion_date":"2020-06-25","primary_completion_date_type":"ACTUAL","completion_date":"2020-06-25","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}